Capital Prioritization with a 25 Percent Funding Gap
A 200-bed critical access hospital has $750,000 in FY capital. Five requests are on the table: 14 of 60 infusion pumps ($196,000) that are 11 years old, with 41% of the fleet already past the manufacturer's end-of-support date; a replacement CT tube ($310,000) for a 9-year-old scanner with an estimated 3 years of service life remaining; four ventilators ($260,000) replacing units that failed to deliver a breath on 22% of self-tests last quarter; a $240,000 ICU monitor refresh; and surgical lights that facilities says can wait a year. Total requests come to $1,006,000. The CFO is a finance generalist, the CNO started eight weeks ago, and last year's capital cycle was decided mostly by who asked first. The hospital is a nonprofit with a line of credit at 6.5% and no appetite for tax-driven depreciation strategies.
1. Rank the requests and show the criteria you used. State what you would fund, what you would defer, and what you would not fund at all.
Read the worked answer
Use five criteria and say them out loud so the ranking is reproducible: patient safety hazard, loss of clinical service, regulatory or accreditation exposure, total cost of ownership and remaining life, and irreversibility (can the decision be reversed cheaply next cycle).
1. Ventilators - fund ($260,000). A 22% self-test failure rate is an active hazard, not a degradation, and there is no realistic backup if two units fail simultaneously. Safety dominates.
2. Infusion pumps - fund ($196,000). 41% past end-of-support means no parts, no firmware, and no security patching, and 14 units is thin for contingency. This is a compliance and cybersecurity exposure as much as a clinical one.
3. CT tube - fund ($310,000) only if the scanner is not on a replacement path. It is predictable and plannable, the remaining life justifies it, but confirm prorated warranty credit on the failed tube and whether imaging is already in the 3-year capital plan. If replacement is imminent, the tube money is stranded.
4. ICU monitors - defer. Acceptable if the current units remain supported; convert to a lease next cycle.
5. Surgical lights - defer, no funding.
Ventilators plus pumps is $456,000, leaving $294,000. Fully funding the tube exceeds the budget, so either use the line of credit for the gap with an explicit carrying-cost figure, or phase the tube into Q1 of next FY with a written commitment.
2. Radiology asks whether to lease the pumps instead of buying them. Walk through the analysis and the assumptions that drive the answer.
Read the worked answer
Compare net present value over the full useful life, not monthly payment against purchase price.
Buy: $196,000 capex plus post-warranty service (assume $15-20k/yr from year 3) plus battery replacement, less residual value at year 7. Because the hospital is a nonprofit and pays no meaningful tax, there is no depreciation shield to offset the cost - the classic reason leases look better on paper to for-profit entities does not apply here.
Lease: lower annual cash outlay and often bundles software, drug library updates, and service. Over a full 7-year life, leases typically cost 15-25% more in nominal terms. That premium buys real things: budget flexibility, technology refresh, and no residual-value risk.
Decision drivers: (a) does the lease bundle the drug library and interoperability software you would otherwise buy separately, (b) what is the renewal and buyout language, (c) does the lease obligate you for the full term if volume drops - critical at a 200-bed rural hospital, and (d) opportunity cost: $196,000 of capital preserved is $196,000 available for the CT tube.
A defensible answer: lease the pumps if the bundled software and refresh terms are genuinely favorable and the total lease cost over 7 years is within about 15% of purchase plus service; otherwise buy. Put the numbers in the memo either way, including the 6.5% line-of-credit cost if the gap is financed.
3. The CNO asks how to make this decision process repeatable so it is not relitigated every year. What do you recommend?
Read the worked answer
Recommend a standing capital prioritization rubric with three properties: it is written before the requests arrive, it is scored by a group rather than an individual, and it produces a ranked list with the unfunded items still documented.
Elements:
- Scored criteria with published weights (safety hazard, service loss, compliance exposure, remaining life, TCO), plus a mandatory 'do nothing' consequence statement for each request.
- Mandatory inputs: device age versus expected life, end-of-support status, service history and cost per year, and failure-mode data. A request without a service history is not scored.
- A single ranked list, with everything below the funding line carried forward with its score, so next year starts from a documented position instead of a blank page.
- A named clinical sponsor per request who must defend it, and a rule that the CNO and CFO sign the final list jointly.
- A short post-cycle review: were the funded items delivered, and did the predicted failure materialize?
The CNO's leverage is that a rubric protects the clinical argument from being outvoted by whoever has the loudest voice. Offer to run one cycle as a pilot and bring the scored list to the next capital committee.